These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Coactivator peptides have a differential stabilizing effect on the binding of estrogens and antiestrogens with the estrogen receptor. Gee AC; Carlson KE; Martini PG; Katzenellenbogen BS; Katzenellenbogen JA Mol Endocrinol; 1999 Nov; 13(11):1912-23. PubMed ID: 10551784 [TBL] [Abstract][Full Text] [Related]
4. In vitro fluorescence anisotropy analysis of the interaction of full-length SRC1a with estrogen receptors alpha and beta supports an active displacement model for coregulator utilization. Wang S; Zhang C; Nordeen SK; Shapiro DJ J Biol Chem; 2007 Feb; 282(5):2765-75. PubMed ID: 17135255 [TBL] [Abstract][Full Text] [Related]
5. Estrogen response element-dependent regulation of transcriptional activation of estrogen receptors alpha and beta by coactivators and corepressors. Klinge CM; Jernigan SC; Mattingly KA; Risinger KE; Zhang J J Mol Endocrinol; 2004 Oct; 33(2):387-410. PubMed ID: 15525597 [TBL] [Abstract][Full Text] [Related]
6. Ligand-independent interactions of p160/steroid receptor coactivators and CREB-binding protein (CBP) with estrogen receptor-alpha: regulation by phosphorylation sites in the A/B region depends on other receptor domains. Dutertre M; Smith CL Mol Endocrinol; 2003 Jul; 17(7):1296-314. PubMed ID: 12714702 [TBL] [Abstract][Full Text] [Related]
7. Temporally distinct and ligand-specific recruitment of nuclear receptor-interacting peptides and cofactors to subnuclear domains containing the estrogen receptor. Schaufele F; Chang CY; Liu W; Baxter JD; Nordeen SK; Wan Y; Day RN; McDonnell DP Mol Endocrinol; 2000 Dec; 14(12):2024-39. PubMed ID: 11117532 [TBL] [Abstract][Full Text] [Related]
8. The pure estrogen receptor antagonist ICI 182,780 promotes a novel interaction of estrogen receptor-alpha with the 3',5'-cyclic adenosine monophosphate response element-binding protein-binding protein/p300 coactivators. Jaber BM; Gao T; Huang L; Karmakar S; Smith CL Mol Endocrinol; 2006 Nov; 20(11):2695-710. PubMed ID: 16840538 [TBL] [Abstract][Full Text] [Related]
9. A homogeneous in vitro functional assay for estrogen receptors: coactivator recruitment. Liu J; Knappenberger KS; Kack H; Andersson G; Nilsson E; Dartsch C; Scott CW Mol Endocrinol; 2003 Mar; 17(3):346-55. PubMed ID: 12554768 [TBL] [Abstract][Full Text] [Related]
11. Multiple transcription factor elements collaborate with estrogen receptor alpha to activate an inducible estrogen response element in the NKG2E gene. Levy N; Zhao X; Tang H; Jaffe RB; Speed TP; Leitman DC Endocrinology; 2007 Jul; 148(7):3449-58. PubMed ID: 17395694 [TBL] [Abstract][Full Text] [Related]
12. Hierarchical affinities and a bipartite interaction model for estrogen receptor isoforms and full-length steroid receptor coactivator (SRC/p160) family members. Cheskis BJ; McKenna NJ; Wong CW; Wong J; Komm B; Lyttle CR; O'Malley BW J Biol Chem; 2003 Apr; 278(15):13271-7. PubMed ID: 12540843 [TBL] [Abstract][Full Text] [Related]
13. CIA, a novel estrogen receptor coactivator with a bifunctional nuclear receptor interacting determinant. Sauvé F; McBroom LD; Gallant J; Moraitis AN; Labrie F; Giguère V Mol Cell Biol; 2001 Jan; 21(1):343-53. PubMed ID: 11113208 [TBL] [Abstract][Full Text] [Related]
14. Breast cancer-derived M543V mutation in helix 12 of estrogen receptor alpha inverts response to estrogen and SERMs. Nichols M; Cheng P; Liu Y; Kanterewicz B; Hershberger PA; McCarty KS Breast Cancer Res Treat; 2010 Apr; 120(3):761-8. PubMed ID: 19526339 [TBL] [Abstract][Full Text] [Related]
15. Nuclear receptor-binding sites of coactivators glucocorticoid receptor interacting protein 1 (GRIP1) and steroid receptor coactivator 1 (SRC-1): multiple motifs with different binding specificities. Ding XF; Anderson CM; Ma H; Hong H; Uht RM; Kushner PJ; Stallcup MR Mol Endocrinol; 1998 Feb; 12(2):302-13. PubMed ID: 9482670 [TBL] [Abstract][Full Text] [Related]
16. Cooperative activation of gene expression by agonists and antagonists mediated by estrogen receptor heteroligand dimer complexes. Liu S; Han SJ; Smith CL Mol Pharmacol; 2013 May; 83(5):1066-77. PubMed ID: 23462505 [TBL] [Abstract][Full Text] [Related]
17. Tamoxifen and ICI 182,780 negatively influenced cardiac cell growth via an estrogen receptor-independent mechanism. Mercier I; Mader S; Calderone A Cardiovasc Res; 2003 Oct; 59(4):883-92. PubMed ID: 14553828 [TBL] [Abstract][Full Text] [Related]
18. Selective estrogen-receptor modulators suppress microglial activation and neuronal cell death via an estrogen receptor-dependent pathway. Ishihara Y; Itoh K; Ishida A; Yamazaki T J Steroid Biochem Mol Biol; 2015 Jan; 145():85-93. PubMed ID: 25305410 [TBL] [Abstract][Full Text] [Related]
19. Molecular mechanisms of selective estrogen receptor modulator activity in human breast cancer cells: identification of novel nuclear cofactors of antiestrogen-ERα complexes by interaction proteomics. Cirillo F; Nassa G; Tarallo R; Stellato C; De Filippo MR; Ambrosino C; Baumann M; Nyman TA; Weisz A J Proteome Res; 2013 Jan; 12(1):421-31. PubMed ID: 23170835 [TBL] [Abstract][Full Text] [Related]
20. Activity of estradiol and selective estrogen receptor modulators in the mouse N20.1 oligodendrocyte/astrocytes cell line. Guzmán CB; Deighton-Collins S; Martinez A; Kleerekoper M; Zhao C; Benjamins JA; Skafar DF Neuro Endocrinol Lett; 2005 Oct; 26(5):526-32. PubMed ID: 16264406 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]